Transform your skincare routine with The Ordinary Azelaic Acid Suspension 10%. This lightweight cream-gel formula is designed to brighten your complexion while enhancing skin texture and reducing the appearance of blemishes. With a high concentration of 10% azelaic acid, this product works wonders for all skin types, particularly for those dealing with acne-prone or dull skin.
Product Features:
- Key Ingredient: 10% Azelaic Acid, a naturally occurring compound known for its anti-inflammatory and skin-brightening properties.
- Texture: Lightweight, non-greasy cream-gel that absorbs quickly.
- Compatibility: Suitable for all skin types, including sensitive skin.
- Multifunctional: Acts as an effective antioxidant while targeting uneven skin tone and texture.
Benefits:
- Brightens Skin: Helps improve skin radiance and overall complexion.
- Reduces Blemishes: Minimizes the appearance of acne and post-inflammatory marks.
- Improves Texture: Promotes smoother skin by refining texture and evening out tone.
- Safe for Daily Use: Well-tolerated by most skin types, making it a versatile addition to your skincare regimen.
Usage:
- Application: Apply a thin layer to clean, dry skin on the face and neck in the morning and/or evening.
- Avoid: Keep away from the eye and mouth areas.
- Sun Protection: Use sunscreen during the day when using this product.
- Patch Test: Recommended prior to use to check for sensitivity.
Elevate your skincare routine and achieve a radiant, clear complexion with The Ordinary Azelaic Acid Suspension 10%. Perfect for daily use, this powerful formula promises visible improvements with consistent application.

SIMPLE HYDRATING LIGHT MOISTURIZER 125ML
DR RASHEL NIACINAMIDE WHITENING FACE WASH
FACE FACTS CAFFEINE SERUM 30ml
Face Facts Vitamin C Body Lotion 400ml
ADVANCED CLINICALS ANTI AGING COLLAGEN SCRUB
ADVANCED CLINICALS Vitamin C Advanced Brightening Cream - 454g
Dr.Rashel Vitamin C Brightening & Anti-Aging Skin Care Series 5in1 Set
CERAVE SA SMOOTHING CLEANSER 473ML 


Reviews
There are no reviews yet.